Biomedicines · 2022 · 67 citations · 18 references
VaccinationVaccine SafetyVaccinologyLnp UptakeVaccine DevelopmentTransmission Electron MicroscopyVaccine ResearchVaccine SurveillanceImmunologyVaccine TestingTherapeutic VaccineVirologyVaccine MrnaMedicineCell BiologyDays Post-vaccinationCovid-19 Mrna Vaccines
COVID-19 mRNA vaccines effectively reduce incidence of severe disease, hospitalisation and death. The biodistribution and pharmacokinetics of the mRNA-containing lipid nanoparticles (LNPs) in these vaccines are unknown in humans. In this study, we used qPCR to track circulating mRNA in blood at different time-points after BNT162b2 vaccination in a small cohort of healthy individuals. We found that vaccine-associated synthetic mRNA persists in systemic circulation for at least 2 weeks. Furthermore, we used transmission electron microscopy (TEM) to investigate SARS-CoV-2 spike protein expression in human leukemic cells and in primary mononuclear blood cells treated in vitro with the BNT162b2 vaccine. TEM revealed morphological changes suggestive of LNP uptake, but only a small fraction of K562 leukemic cells presented spike-like structures at the cell surface, suggesting reduced levels of expression for these specific phenotypes.
18
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.4K citations · Full text
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 1.6K citations · Full text
Structure-guided High-resolution Serology, Virus Structure, Immunodominant Sites +5